VEGFR2/CD309 Antikörper (AA 1057-1061)
Kurzübersicht für VEGFR2/CD309 Antikörper (AA 1057-1061) (ABIN5689591)
Target
Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1057-1061
-
Spezifität
- This antibody detects endogenous levels of total VEGFR2 protein.
-
Aufreinigung
- Antibodies were purified by affinity-chromatography using epitope-specific peptide.
-
Immunogen
- VEGFR2 (Ab-1059) antibody was raised against a peptide sequence around aa. 1057~1061 (P-D-Y-V-R) derived from Human VEGFR2.
-
-
-
-
Applikationshinweise
- Western Blot: 1:1000
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store antibody at -20°C for up to one year.
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Andere Bezeichnung
- VEGFR2
-
Hintergrund
- Receptor for VEGF or VEGFC. Has a tyrosine-protein kinase activity. The VEGF-kinase ligand/receptor signaling system plays a key role in vascular development and regulation of vascular permeability. In case of HIV-1 infection, the interaction with extracellular viral Tat protein seems to enhance angiogenesis in Kaposi's sarcoma lesions
-
Molekulargewicht
- 210, 230 kDa
-
Gen-ID
- 3791
-
NCBI Accession
- NP_002244
-
UniProt
- P35968
-
Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-